Ropes Wealth Advisors LLC Reduces Position in CME Group Inc (CME)

Ropes Wealth Advisors LLC lessened its holdings in shares of CME Group Inc (NASDAQ:CME) by 6.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,206 shares of the financial services provider’s stock after selling 435 shares during the period. Ropes Wealth Advisors LLC’s holdings in CME Group were worth $1,056,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in CME. Summit Trail Advisors LLC grew its stake in shares of CME Group by 44.9% in the 1st quarter. Summit Trail Advisors LLC now owns 3,983 shares of the financial services provider’s stock valued at $262,000 after buying an additional 1,235 shares during the period. Brown Advisory Inc. grew its stake in shares of CME Group by 5.4% in the 1st quarter. Brown Advisory Inc. now owns 28,017 shares of the financial services provider’s stock valued at $4,532,000 after buying an additional 1,429 shares during the period. Private Trust Co. NA purchased a new stake in shares of CME Group in the 2nd quarter valued at approximately $231,000. DnB Asset Management AS grew its stake in shares of CME Group by 8.4% in the 2nd quarter. DnB Asset Management AS now owns 41,415 shares of the financial services provider’s stock valued at $6,789,000 after buying an additional 3,200 shares during the period. Finally, First American Trust FSB grew its stake in shares of CME Group by 4.1% in the 2nd quarter. First American Trust FSB now owns 16,167 shares of the financial services provider’s stock valued at $2,650,000 after buying an additional 639 shares during the period. 84.29% of the stock is owned by institutional investors.

Several research firms have recently weighed in on CME. Zacks Investment Research raised shares of CME Group from a “sell” rating to a “hold” rating in a research note on Tuesday, September 18th. Compass Point began coverage on shares of CME Group in a research note on Monday, July 9th. They issued a “neutral” rating and a $170.00 price target for the company. BidaskClub cut shares of CME Group from a “buy” rating to a “hold” rating in a research note on Tuesday, July 10th. Deutsche Bank reissued a “buy” rating and issued a $192.00 price target (up previously from $185.00) on shares of CME Group in a research note on Thursday, October 11th. Finally, Wells Fargo & Co increased their price target on shares of CME Group from $175.00 to $177.00 and gave the company a “market perform” rating in a research note on Friday, October 26th. Five equities research analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the stock. CME Group presently has an average rating of “Buy” and a consensus target price of $181.54.

In other CME Group news, CAO Jack J. Tobin sold 7,820 shares of the stock in a transaction that occurred on Wednesday, September 5th. The shares were sold at an average price of $174.87, for a total transaction of $1,367,483.40. Following the sale, the chief accounting officer now directly owns 17,534 shares in the company, valued at approximately $3,066,170.58. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, President Bryan T. Durkin sold 11,509 shares of the stock in a transaction that occurred on Monday, August 6th. The stock was sold at an average price of $162.01, for a total transaction of $1,864,573.09. Following the sale, the president now owns 64,862 shares in the company, valued at $10,508,292.62. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 29,188 shares of company stock worth $4,973,607. Company insiders own 0.43% of the company’s stock.

Shares of CME stock opened at $182.75 on Wednesday. The company has a current ratio of 1.09, a quick ratio of 1.08 and a debt-to-equity ratio of 0.15. CME Group Inc has a one year low of $135.61 and a one year high of $183.79. The company has a market capitalization of $60.65 billion, a PE ratio of 38.25, a P/E/G ratio of 3.38 and a beta of 0.64.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Thursday, October 25th. The financial services provider reported $1.45 EPS for the quarter, topping the consensus estimate of $1.42 by $0.03. CME Group had a net margin of 113.67% and a return on equity of 9.18%. The firm had revenue of $904.20 million for the quarter, compared to analyst estimates of $910.50 million. Equities analysts expect that CME Group Inc will post 6.63 earnings per share for the current year.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Read More: How to invest in a bear market

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply